Emibetuzumab
|
|
Emibetuzumab 속성
안전
Emibetuzumab C화학적 특성, 용도, 생산
개요
Emibetuzumab is a bivalent antibody that blocks HGF- and MET-receptor interaction, leading to MET internalization and degradation.Clinical Use
A phase I study determined a tolerable dose for emibetuzumab to be 700–2000 mg as a monotherapy and in combination with erlotinib in NSCLC patients. It is currently being investigated in phase II in combination with erlotinib.Emibetuzumab 준비 용품 및 원자재
원자재
준비 용품
Emibetuzumab 공급 업체
글로벌( 8)공급 업체
| 공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
|---|---|---|---|---|---|
| Aladdin Scientific | +1-+1(833)-552-7181 |
sales@aladdinsci.com | United States | 57511 | 58 |
| ShangHai Biochempartner Co.,Ltd | 17754423994 17754423994 |
2853530910@QQ.com | China | 8011 | 62 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 |
422450190@qq.com | China | 10061 | 58 |
| AntibodySystem | 027-65279366 18162686757 |
biolab-reagents@atagenix.com | China | 9817 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 13720134139 |
orders@jknbiochem.com | China | 5285 | 58 |
| Shanghai Aladdin Biochemical Technology Co.,Ltd. | +86-18521732826 |
market@aladdin-e.com | China | 48467 | 58 |
| Changsha Fuzhen Biotechnology Co.，LTD | 0731-18670069958 18670069958 |
184792226@qq.com | China | 3060 | 58 |
| Olix (Shanghai) Pharmaceutical Technology Co., Ltd | 17316404525 |
209533805@qq.com | China | 9661 | 58 |